866-997-4948(US-Canada Toll Free)

Global Hyaluronic Acid Market 2017-2021

Published By :

Technavio

Published Date : Sep 2017

Category :

Chemicals

No. of Pages : 86 Pages

About Hyaluronic Acid

HA is an anionic and non-sulfated glycosaminoglycan, which is present in human body especially in the joints in the form of fluids; it acts as a lubricant, thereby providing a cushioning effect. HA is primarily used in medical and cosmetic applications such as dermal fillers, osteoarthritis, ophthalmic surgery, and VUR. In addition, it helps in the healing of wounds. The rising demand for cosmetics and non-surgical procedures is expected to drive the growth of the HA market.

Technavios analysts forecast the global hyaluronic acid market to grow at a CAGR of 8.7% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global hyaluronic acid market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
APAC
Europe
North America
ROW

Technavio's report, Global Hyaluronic Acid Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
ALLERGAN
Anika Therapeutics
Sanofi
SEIKAGAKU
Zimmer Biomet

Other prominent vendors
Contipro
Ferring
Fidia Farmaceutici
Galderma
Hyalogic
HYALTECH
Lifecore Biomedical
Maruha Nichiro
Meiji Holdings
Merz Pharma
Rayner
Shiseido
TRB CHEMEDICA INTERNATIONAL
Valeant

Market driver
Increased ailments among the growing aging population
For a full, detailed list, view our report

Market challenge
Intense competition leading to reduced ASP
For a full, detailed list, view our report

Market trend
Production of HA with cost-effective raw materials
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global HA market by product type
Global five-injection cycle HA market
Global three-injection cycle HA market
Global single-injection cycle HA market
PART 07: Market segmentation by application
Global HA market by application
Global HA market in the dermal fillers segment
Global HA market in the osteoarthritis segment
Global HA market in the ophthalmic surgery segment
Global HA market in the VUR segment
PART 08: Geographical segmentation
Global HA market by geography
HA market in North America
HA market in Europe
HA market in APAC
HA market in ROW
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Production of HA with cost-effective raw materials
Rising substitutes for HA
PART 12: Vendor landscape
Competitive scenario
Key market vendors
Other prominent vendors
PART 13: Key vendor analysis
ALLERGAN
Anika Therapeutics
Sanofi
SEIKAGAKU
Zimmer Biomet
PART 14: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Synonyms of HA
Exhibit 02: Synthesis of HA (process flow)
Exhibit 03: Segmentation of global HA market
Exhibit 04: Global HA market 2016 and 2021 ($ millions)
Exhibit 05: Market forecast: Global HA market 2016-2021
Exhibit 06: Five forces analysis
Exhibit 07: Global HA market by product type 2016 (% share of revenue)
Exhibit 08: Global HA market by product type 2021 (% share of revenue)
Exhibit 09: Global five-injection cycle HA market 2016 and 2021 ($ millions)
Exhibit 10: Market forecast: Global five-injection cycle HA market 2016-2021
Exhibit 11: Global three-injection cycle HA market 2016 and 2021 ($ millions)
Exhibit 12: Market forecast: Global three-injection cycle HA market 2016-2021
Exhibit 13: Global single-injection cycle HA market 2016 and 2021 ($ millions)
Exhibit 14: Market forecast: Global single-injection cycle HA market 2016-2021
Exhibit 15: Global HA market by application 2016 (% share of revenue)
Exhibit 16: Global HA market by application 2021 (% share of revenue)
Exhibit 17: Global HA market in the dermal fillers segment 2016 and 2021 ($ millions)
Exhibit 18: Market forecast: Global HA market in the dermal fillers segment 2016-2021
Exhibit 19: Global HA market in the osteoarthritis segment 2016 and 2021 ($ millions)
Exhibit 20: Market forecast: Global HA market in the osteoarthritis segment 2016-2021
Exhibit 21: Global HA market in the ophthalmic surgery segment 2016 and 2021 ($ millions)
Exhibit 22: Market forecast: Global HA market in the ophthalmic surgery segment 2016-2021
Exhibit 23: Global HA market in the VUR segment 2016 and 2021 ($ millions)
Exhibit 24: Market forecast: Global HA market in the VUR segment 2016-2021
Exhibit 25: Global HA market by geography 2016 (% share of revenue)
Exhibit 26: Global HA market by geography 2021 (% share of revenue)
Exhibit 27: HA market in North America 2016 and 2021 ($ millions)
Exhibit 28: Market forecast: HA market in North America 2016-2021
Exhibit 29: HA market in Europe 2016 and 2021 ($ millions)
Exhibit 30: Market forecast: HA market in Europe 2016-2021
Exhibit 31: HA market in APAC 2016 and 2021 ($ millions)
Exhibit 32: Market forecast: HA market in APAC 2016-2021
Exhibit 33: HA market in ROW 2016 and 2021 ($ millions)
Exhibit 34: Market forecast: HA market in ROW 2016-2021
Exhibit 35: Population of age 65 years and above (% of total population) (2005-2016)
Exhibit 36: Applications of HA in dermal fillers
Exhibit 37: Side effects of HA
Exhibit 38: Key market vendors
Exhibit 39: ALLERGAN: Business segmentation by revenue 2016 (% share)
Exhibit 40: Anika Therapeutics: Business segmentation by revenue 2016 (% share)
Exhibit 41: Anika Therapeutics: Geographical segmentation by revenue 2016 (% share)
Exhibit 42: Sanofi: Business segmentation by revenue 2016 (% share)
Exhibit 43: Sanofi: Geographical segmentation by revenue 2016 (% share)
Exhibit 44: SEIKAGAKU: Business segmentation by revenue 2016 (% share)
Exhibit 45: SEIKAGAKU: Geographical segmentation by revenue 2016 (% share)
Exhibit 46: Zimmer Biomet: Business segmentation by revenue 2016 (% share)
Exhibit 47: Zimmer Biomet: Geographical segmentation by revenue 2016 (% share)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *